Zitrazole-IT Anti Fungal Cream is a potent topical formulation combining Ofloxacin (0.75% w/w), Ornidazole (2% w/w), Itraconazole (1% w/w), and Clobetasol (0.05% w/w) designed for the effective management of mixed fungal and bacterial skin infections accompanied by inflammation and pruritus. Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets bacterial pathogens by inhibiting DNA gyrase, thereby preventing bacterial replication. Ornidazole, a nitroimidazole derivative, exhibits activity against anaerobic bacteria and protozoa, enhancing the antimicrobial spectrum. Itraconazole, a triazole antifungal agent, impedes fungal cell membrane synthesis by inhibiting ergosterol production, effectively treating dermatophytic and yeast infections. Clobetasol propionate, a potent corticosteroid, provides anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing erythema, swelling, and discomfort associated with inflammatory dermatoses. This combination cream is indicated for dermatophytosis, candidiasis, mixed bacterial-fungal infections, and inflammatory dermatoses where secondary infection is present. Application should be limited to affected areas, avoiding prolonged use to minimize potential corticosteroid-related adverse effects such as skin atrophy. Contraindications include hypersensitivity to any component and viral or tubercular skin infections. Zitrazole-IT offers a comprehensive therapeutic approach, addressing infection and inflammation simultaneously to promote rapid symptom resolution and skin healing.